nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—SLC18A2—blood plasma—systemic lupus erythematosus	0.0263	0.0469	CbGeAlD
Methamphetamine—TAAR1—lung—systemic lupus erythematosus	0.0248	0.0443	CbGeAlD
Methamphetamine—SLC18A1—nervous system—systemic lupus erythematosus	0.0245	0.0437	CbGeAlD
Methamphetamine—SLC18A1—central nervous system—systemic lupus erythematosus	0.0235	0.042	CbGeAlD
Methamphetamine—TAAR1—nervous system—systemic lupus erythematosus	0.023	0.0411	CbGeAlD
Methamphetamine—TAAR1—central nervous system—systemic lupus erythematosus	0.0221	0.0395	CbGeAlD
Methamphetamine—SLC6A4—blood plasma—systemic lupus erythematosus	0.0182	0.0325	CbGeAlD
Methamphetamine—MAOB—blood plasma—systemic lupus erythematosus	0.0173	0.0309	CbGeAlD
Methamphetamine—CYP2D6—urine—systemic lupus erythematosus	0.0168	0.03	CbGeAlD
Methamphetamine—MAOA—blood plasma—systemic lupus erythematosus	0.0148	0.0264	CbGeAlD
Methamphetamine—Digestion impaired—Leflunomide—systemic lupus erythematosus	0.0128	0.044	CcSEcCtD
Methamphetamine—Psychotic disorder—Dapsone—systemic lupus erythematosus	0.0113	0.0391	CcSEcCtD
Methamphetamine—ADRA2A—blood plasma—systemic lupus erythematosus	0.0113	0.0202	CbGeAlD
Methamphetamine—Pseudoephedrine—IL2—systemic lupus erythematosus	0.0103	0.557	CrCbGaD
Methamphetamine—SLC22A3—connective tissue—systemic lupus erythematosus	0.00996	0.0178	CbGeAlD
Methamphetamine—Digestion impaired—Cyclosporine—systemic lupus erythematosus	0.00986	0.034	CcSEcCtD
Methamphetamine—SLC18A2—tendon—systemic lupus erythematosus	0.00961	0.0172	CbGeAlD
Methamphetamine—MAOB—connective tissue—systemic lupus erythematosus	0.00922	0.0165	CbGeAlD
Methamphetamine—MAOB—nephron tubule—systemic lupus erythematosus	0.00893	0.0159	CbGeAlD
Methamphetamine—CYP2D6—blood plasma—systemic lupus erythematosus	0.00878	0.0157	CbGeAlD
Methamphetamine—SLC22A3—kidney—systemic lupus erythematosus	0.00848	0.0151	CbGeAlD
Methamphetamine—SLC18A2—lung—systemic lupus erythematosus	0.00844	0.0151	CbGeAlD
Methamphetamine—MAOA—connective tissue—systemic lupus erythematosus	0.00786	0.014	CbGeAlD
Methamphetamine—MAOB—kidney—systemic lupus erythematosus	0.00785	0.014	CbGeAlD
Methamphetamine—SLC18A2—nervous system—systemic lupus erythematosus	0.00781	0.014	CbGeAlD
Methamphetamine—MAOB—cortex of kidney—systemic lupus erythematosus	0.00764	0.0136	CbGeAlD
Methamphetamine—MAOA—nephron tubule—systemic lupus erythematosus	0.00762	0.0136	CbGeAlD
Methamphetamine—SLC18A2—central nervous system—systemic lupus erythematosus	0.00752	0.0134	CbGeAlD
Methamphetamine—ADRA2C—nephron tubule—systemic lupus erythematosus	0.00732	0.0131	CbGeAlD
Methamphetamine—SLC22A5—nephron tubule—systemic lupus erythematosus	0.00702	0.0125	CbGeAlD
Methamphetamine—MAOA—kidney—systemic lupus erythematosus	0.00669	0.012	CbGeAlD
Methamphetamine—SLC22A5—skin of body—systemic lupus erythematosus	0.00654	0.0117	CbGeAlD
Methamphetamine—MAOA—cortex of kidney—systemic lupus erythematosus	0.00652	0.0116	CbGeAlD
Methamphetamine—ADRA2C—kidney—systemic lupus erythematosus	0.00644	0.0115	CbGeAlD
Methamphetamine—SLC6A3—lung—systemic lupus erythematosus	0.00638	0.0114	CbGeAlD
Methamphetamine—MAOB—tendon—systemic lupus erythematosus	0.00633	0.0113	CbGeAlD
Methamphetamine—ADRA2C—cortex of kidney—systemic lupus erythematosus	0.00627	0.0112	CbGeAlD
Methamphetamine—SLC22A5—kidney—systemic lupus erythematosus	0.00616	0.011	CbGeAlD
Methamphetamine—ADRA2A—connective tissue—systemic lupus erythematosus	0.00603	0.0108	CbGeAlD
Methamphetamine—SLC22A3—lung—systemic lupus erythematosus	0.00601	0.0107	CbGeAlD
Methamphetamine—SLC22A5—cortex of kidney—systemic lupus erythematosus	0.006	0.0107	CbGeAlD
Methamphetamine—SLC6A3—nervous system—systemic lupus erythematosus	0.00591	0.0106	CbGeAlD
Methamphetamine—SLC6A4—lung—systemic lupus erythematosus	0.00585	0.0104	CbGeAlD
Methamphetamine—SLC6A3—central nervous system—systemic lupus erythematosus	0.00569	0.0102	CbGeAlD
Methamphetamine—Tachycardia—Dapsone—systemic lupus erythematosus	0.00557	0.0192	CcSEcCtD
Methamphetamine—SLC22A3—nervous system—systemic lupus erythematosus	0.00556	0.00994	CbGeAlD
Methamphetamine—MAOB—lung—systemic lupus erythematosus	0.00556	0.00993	CbGeAlD
Methamphetamine—SLC6A4—nervous system—systemic lupus erythematosus	0.00541	0.00967	CbGeAlD
Methamphetamine—MAOA—tendon—systemic lupus erythematosus	0.0054	0.00965	CbGeAlD
Methamphetamine—SLC22A3—central nervous system—systemic lupus erythematosus	0.00536	0.00957	CbGeAlD
Methamphetamine—SLC6A4—central nervous system—systemic lupus erythematosus	0.00521	0.00931	CbGeAlD
Methamphetamine—ADRA2C—tendon—systemic lupus erythematosus	0.0052	0.00928	CbGeAlD
Methamphetamine—Insomnia—Dapsone—systemic lupus erythematosus	0.00516	0.0178	CcSEcCtD
Methamphetamine—Euphoric mood—Prednisolone—systemic lupus erythematosus	0.00515	0.0178	CcSEcCtD
Methamphetamine—MAOB—nervous system—systemic lupus erythematosus	0.00515	0.00919	CbGeAlD
Methamphetamine—SLC6A2—lung—systemic lupus erythematosus	0.00515	0.00919	CbGeAlD
Methamphetamine—Euphoric mood—Hydrocortisone—systemic lupus erythematosus	0.00503	0.0173	CcSEcCtD
Methamphetamine—ADRA2A—cortex of kidney—systemic lupus erythematosus	0.005	0.00893	CbGeAlD
Methamphetamine—SLC22A5—tendon—systemic lupus erythematosus	0.00498	0.00889	CbGeAlD
Methamphetamine—MAOB—central nervous system—systemic lupus erythematosus	0.00496	0.00885	CbGeAlD
Methamphetamine—SLC6A2—nervous system—systemic lupus erythematosus	0.00477	0.00851	CbGeAlD
Methamphetamine—MAOA—lung—systemic lupus erythematosus	0.00474	0.00847	CbGeAlD
Methamphetamine—Euphoric mood—Triamcinolone—systemic lupus erythematosus	0.00474	0.0163	CcSEcCtD
Methamphetamine—Euphoric mood—Methylprednisolone—systemic lupus erythematosus	0.00473	0.0163	CcSEcCtD
Methamphetamine—SLC6A2—central nervous system—systemic lupus erythematosus	0.00459	0.0082	CbGeAlD
Methamphetamine—ADRA2C—lung—systemic lupus erythematosus	0.00456	0.00815	CbGeAlD
Methamphetamine—Psychotic disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00456	0.0157	CcSEcCtD
Methamphetamine—MAOA—nervous system—systemic lupus erythematosus	0.00439	0.00784	CbGeAlD
Methamphetamine—SLC22A5—lung—systemic lupus erythematosus	0.00437	0.0078	CbGeAlD
Methamphetamine—Euphoric mood—Betamethasone—systemic lupus erythematosus	0.0043	0.0148	CcSEcCtD
Methamphetamine—Euphoric mood—Dexamethasone—systemic lupus erythematosus	0.0043	0.0148	CcSEcCtD
Methamphetamine—MAOA—central nervous system—systemic lupus erythematosus	0.00423	0.00755	CbGeAlD
Methamphetamine—ADRA2C—nervous system—systemic lupus erythematosus	0.00422	0.00754	CbGeAlD
Methamphetamine—Psychotic disorder—Hydrocortisone—systemic lupus erythematosus	0.00415	0.0143	CcSEcCtD
Methamphetamine—ADRA2A—tendon—systemic lupus erythematosus	0.00415	0.00741	CbGeAlD
Methamphetamine—ADRA2C—central nervous system—systemic lupus erythematosus	0.00407	0.00726	CbGeAlD
Methamphetamine—CYP2D6—kidney—systemic lupus erythematosus	0.00398	0.00711	CbGeAlD
Methamphetamine—Psychotic disorder—Methylprednisolone—systemic lupus erythematosus	0.0039	0.0134	CcSEcCtD
Methamphetamine—Euphoric mood—Prednisone—systemic lupus erythematosus	0.00375	0.0129	CcSEcCtD
Methamphetamine—Erectile dysfunction—Mycophenolate mofetil—systemic lupus erythematosus	0.00372	0.0128	CcSEcCtD
Methamphetamine—ADRA2A—lung—systemic lupus erythematosus	0.00364	0.0065	CbGeAlD
Methamphetamine—Headache—Dapsone—systemic lupus erythematosus	0.00358	0.0123	CcSEcCtD
Methamphetamine—Psychotic disorder—Betamethasone—systemic lupus erythematosus	0.00355	0.0122	CcSEcCtD
Methamphetamine—Psychotic disorder—Dexamethasone—systemic lupus erythematosus	0.00355	0.0122	CcSEcCtD
Methamphetamine—Pseudoephedrine—TNF—systemic lupus erythematosus	0.00348	0.188	CrCbGaD
Methamphetamine—Nateglinide—PPARG—systemic lupus erythematosus	0.00342	0.185	CrCbGaD
Methamphetamine—ADRA2A—nervous system—systemic lupus erythematosus	0.00337	0.00602	CbGeAlD
Methamphetamine—Palpitations—Leflunomide—systemic lupus erythematosus	0.0033	0.0114	CcSEcCtD
Methamphetamine—ADRA2A—central nervous system—systemic lupus erythematosus	0.00324	0.00579	CbGeAlD
Methamphetamine—Psychotic disorder—Prednisone—systemic lupus erythematosus	0.00309	0.0106	CcSEcCtD
Methamphetamine—Tachycardia—Leflunomide—systemic lupus erythematosus	0.00297	0.0102	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.00279	0.0096	CcSEcCtD
Methamphetamine—Insomnia—Leflunomide—systemic lupus erythematosus	0.00276	0.00949	CcSEcCtD
Methamphetamine—Tremor—Cyclosporine—systemic lupus erythematosus	0.0027	0.0093	CcSEcCtD
Methamphetamine—Dyspepsia—Leflunomide—systemic lupus erythematosus	0.00268	0.00924	CcSEcCtD
Methamphetamine—Agitation—Cyclosporine—systemic lupus erythematosus	0.00265	0.00912	CcSEcCtD
Methamphetamine—Tremor—Mycophenolate mofetil—systemic lupus erythematosus	0.00263	0.00907	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.00263	0.00906	CcSEcCtD
Methamphetamine—CYP2D6—nervous system—systemic lupus erythematosus	0.00261	0.00466	CbGeAlD
Methamphetamine—Constipation—Leflunomide—systemic lupus erythematosus	0.00261	0.00898	CcSEcCtD
Methamphetamine—Agitation—Mycophenolate mofetil—systemic lupus erythematosus	0.00258	0.0089	CcSEcCtD
Methamphetamine—Erectile dysfunction—Prednisone—systemic lupus erythematosus	0.00252	0.00868	CcSEcCtD
Methamphetamine—CYP2D6—central nervous system—systemic lupus erythematosus	0.00251	0.00449	CbGeAlD
Methamphetamine—Palpitations—Mycophenolate mofetil—systemic lupus erythematosus	0.00248	0.00856	CcSEcCtD
Methamphetamine—Urticaria—Leflunomide—systemic lupus erythematosus	0.00242	0.00834	CcSEcCtD
Methamphetamine—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.00238	0.00819	CcSEcCtD
Methamphetamine—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.00225	0.00773	CcSEcCtD
Methamphetamine—Tachycardia—Mycophenolate mofetil—systemic lupus erythematosus	0.00224	0.00771	CcSEcCtD
Methamphetamine—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.00221	0.00761	CcSEcCtD
Methamphetamine—Dizziness—Azathioprine—systemic lupus erythematosus	0.00213	0.00735	CcSEcCtD
Methamphetamine—Insomnia—Cyclosporine—systemic lupus erythematosus	0.00213	0.00733	CcSEcCtD
Methamphetamine—Erectile dysfunction—Methotrexate—systemic lupus erythematosus	0.00211	0.00725	CcSEcCtD
Methamphetamine—Tachycardia—Prednisolone—systemic lupus erythematosus	0.00209	0.00719	CcSEcCtD
Methamphetamine—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.00209	0.00718	CcSEcCtD
Methamphetamine—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.00208	0.00715	CcSEcCtD
Methamphetamine—Dyspepsia—Cyclosporine—systemic lupus erythematosus	0.00207	0.00713	CcSEcCtD
Methamphetamine—Tachycardia—Hydrocortisone—systemic lupus erythematosus	0.00204	0.00703	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.00203	0.00699	CcSEcCtD
Methamphetamine—Headache—Azathioprine—systemic lupus erythematosus	0.00202	0.00696	CcSEcCtD
Methamphetamine—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	0.00202	0.00696	CcSEcCtD
Methamphetamine—Dizziness—Leflunomide—systemic lupus erythematosus	0.00202	0.00694	CcSEcCtD
Methamphetamine—Constipation—Cyclosporine—systemic lupus erythematosus	0.00201	0.00693	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00198	0.00682	CcSEcCtD
Methamphetamine—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.00196	0.00676	CcSEcCtD
Methamphetamine—Insomnia—Prednisolone—systemic lupus erythematosus	0.00194	0.00667	CcSEcCtD
Methamphetamine—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.00192	0.00662	CcSEcCtD
Methamphetamine—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.00192	0.0066	CcSEcCtD
Methamphetamine—Headache—Leflunomide—systemic lupus erythematosus	0.00191	0.00658	CcSEcCtD
Methamphetamine—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.00189	0.00651	CcSEcCtD
Methamphetamine—Urticaria—Cyclosporine—systemic lupus erythematosus	0.00187	0.00644	CcSEcCtD
Methamphetamine—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.00184	0.00634	CcSEcCtD
Methamphetamine—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.00182	0.00628	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.0018	0.00622	CcSEcCtD
Methamphetamine—Insomnia—Triamcinolone—systemic lupus erythematosus	0.00178	0.00613	CcSEcCtD
Methamphetamine—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.00178	0.00612	CcSEcCtD
Methamphetamine—Agitation—Prednisone—systemic lupus erythematosus	0.00175	0.00603	CcSEcCtD
Methamphetamine—Tachycardia—Betamethasone—systemic lupus erythematosus	0.00174	0.006	CcSEcCtD
Methamphetamine—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.00174	0.006	CcSEcCtD
Methamphetamine—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.00173	0.00597	CcSEcCtD
Methamphetamine—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.00173	0.00597	CcSEcCtD
Methamphetamine—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.00173	0.00595	CcSEcCtD
Methamphetamine—Urticaria—Prednisolone—systemic lupus erythematosus	0.0017	0.00586	CcSEcCtD
Methamphetamine—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.00169	0.00582	CcSEcCtD
Methamphetamine—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.00166	0.00572	CcSEcCtD
Methamphetamine—Insomnia—Dexamethasone—systemic lupus erythematosus	0.00162	0.00556	CcSEcCtD
Methamphetamine—Insomnia—Betamethasone—systemic lupus erythematosus	0.00162	0.00556	CcSEcCtD
Methamphetamine—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.00161	0.00554	CcSEcCtD
Methamphetamine—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.00158	0.00543	CcSEcCtD
Methamphetamine—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.00157	0.00541	CcSEcCtD
Methamphetamine—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.00157	0.00541	CcSEcCtD
Methamphetamine—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.00157	0.00541	CcSEcCtD
Methamphetamine—Urticaria—Triamcinolone—systemic lupus erythematosus	0.00156	0.00539	CcSEcCtD
Methamphetamine—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.00156	0.00537	CcSEcCtD
Methamphetamine—Dizziness—Cyclosporine—systemic lupus erythematosus	0.00156	0.00536	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.00154	0.00531	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.00154	0.00531	CcSEcCtD
Methamphetamine—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.00154	0.0053	CcSEcCtD
Methamphetamine—Tachycardia—Prednisone—systemic lupus erythematosus	0.00152	0.00523	CcSEcCtD
Methamphetamine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.00152	0.00523	CcSEcCtD
Methamphetamine—Headache—Cyclosporine—systemic lupus erythematosus	0.00147	0.00508	CcSEcCtD
Methamphetamine—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.00145	0.00499	CcSEcCtD
Methamphetamine—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.00145	0.00498	CcSEcCtD
Methamphetamine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.00144	0.00495	CcSEcCtD
Methamphetamine—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.00143	0.00493	CcSEcCtD
Methamphetamine—Urticaria—Betamethasone—systemic lupus erythematosus	0.00142	0.00489	CcSEcCtD
Methamphetamine—Urticaria—Dexamethasone—systemic lupus erythematosus	0.00142	0.00489	CcSEcCtD
Methamphetamine—Dizziness—Prednisolone—systemic lupus erythematosus	0.00142	0.00487	CcSEcCtD
Methamphetamine—Insomnia—Prednisone—systemic lupus erythematosus	0.00141	0.00485	CcSEcCtD
Methamphetamine—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.00138	0.00476	CcSEcCtD
Methamphetamine—Dyspepsia—Prednisone—systemic lupus erythematosus	0.00137	0.00472	CcSEcCtD
Methamphetamine—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.00134	0.00463	CcSEcCtD
Methamphetamine—Headache—Prednisolone—systemic lupus erythematosus	0.00134	0.00462	CcSEcCtD
Methamphetamine—Constipation—Prednisone—systemic lupus erythematosus	0.00133	0.00458	CcSEcCtD
Methamphetamine—Headache—Hydrocortisone—systemic lupus erythematosus	0.00131	0.00451	CcSEcCtD
Methamphetamine—Dizziness—Triamcinolone—systemic lupus erythematosus	0.0013	0.00448	CcSEcCtD
Methamphetamine—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.0013	0.00447	CcSEcCtD
Methamphetamine—Nateglinide—ALB—systemic lupus erythematosus	0.00128	0.0695	CrCbGaD
Methamphetamine—Urticaria—Prednisone—systemic lupus erythematosus	0.00124	0.00426	CcSEcCtD
Methamphetamine—Headache—Triamcinolone—systemic lupus erythematosus	0.00123	0.00425	CcSEcCtD
Methamphetamine—Headache—Methylprednisolone—systemic lupus erythematosus	0.00123	0.00424	CcSEcCtD
Methamphetamine—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.00122	0.00421	CcSEcCtD
Methamphetamine—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.00122	0.00421	CcSEcCtD
Methamphetamine—Dizziness—Dexamethasone—systemic lupus erythematosus	0.00118	0.00407	CcSEcCtD
Methamphetamine—Dizziness—Betamethasone—systemic lupus erythematosus	0.00118	0.00407	CcSEcCtD
Methamphetamine—Insomnia—Methotrexate—systemic lupus erythematosus	0.00118	0.00405	CcSEcCtD
Methamphetamine—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.00115	0.00395	CcSEcCtD
Methamphetamine—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.00114	0.00394	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.00112	0.00387	CcSEcCtD
Methamphetamine—Headache—Betamethasone—systemic lupus erythematosus	0.00112	0.00385	CcSEcCtD
Methamphetamine—Headache—Dexamethasone—systemic lupus erythematosus	0.00112	0.00385	CcSEcCtD
Methamphetamine—Diarrhoea—Prednisone—systemic lupus erythematosus	0.00106	0.00367	CcSEcCtD
Methamphetamine—Urticaria—Methotrexate—systemic lupus erythematosus	0.00103	0.00356	CcSEcCtD
Methamphetamine—Dizziness—Prednisone—systemic lupus erythematosus	0.00103	0.00354	CcSEcCtD
Methamphetamine—Headache—Prednisone—systemic lupus erythematosus	0.000974	0.00336	CcSEcCtD
Methamphetamine—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000958	0.0033	CcSEcCtD
Methamphetamine—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000889	0.00306	CcSEcCtD
Methamphetamine—Dizziness—Methotrexate—systemic lupus erythematosus	0.00086	0.00296	CcSEcCtD
Methamphetamine—Headache—Methotrexate—systemic lupus erythematosus	0.000814	0.0028	CcSEcCtD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—ALB—systemic lupus erythematosus	0.000119	0.000907	CbGpPWpGaD
Methamphetamine—ADRA2C—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	0.000119	0.000906	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.000119	0.000904	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000118	0.0009	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—RASGRP1—systemic lupus erythematosus	0.000117	0.000893	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—NAT2—systemic lupus erythematosus	0.000117	0.000892	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—C3—systemic lupus erythematosus	0.000116	0.000883	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CD80—systemic lupus erythematosus	0.000115	0.000877	CbGpPWpGaD
Methamphetamine—MAOA—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	0.000112	0.000855	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—JAK1—systemic lupus erythematosus	0.000112	0.000853	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—IL2RA—systemic lupus erythematosus	0.000112	0.000853	CbGpPWpGaD
Methamphetamine—SLC6A4—Circadian rythm related genes—IL6—systemic lupus erythematosus	0.000112	0.000852	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—F2—systemic lupus erythematosus	0.000109	0.00083	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.000109	0.000827	CbGpPWpGaD
Methamphetamine—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	0.000108	0.000824	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	0.000107	0.000817	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000107	0.000817	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CCL2—systemic lupus erythematosus	0.000107	0.000815	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	0.000107	0.000814	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.000105	0.000798	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—RXRA—systemic lupus erythematosus	0.000105	0.000797	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—IL2RA—systemic lupus erythematosus	0.000105	0.000796	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—F2—systemic lupus erythematosus	0.000102	0.000775	CbGpPWpGaD
Methamphetamine—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	0.000101	0.00077	CbGpPWpGaD
Methamphetamine—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	9.93e-05	0.000756	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	9.78e-05	0.000745	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	9.77e-05	0.000744	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—F2—systemic lupus erythematosus	9.74e-05	0.000742	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TYK2—systemic lupus erythematosus	9.72e-05	0.00074	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—CCL2—systemic lupus erythematosus	9.71e-05	0.00074	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	9.68e-05	0.000737	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	9.66e-05	0.000736	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—CCR5—systemic lupus erythematosus	9.64e-05	0.000734	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—NAT2—systemic lupus erythematosus	9.63e-05	0.000734	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—NOS3—systemic lupus erythematosus	9.54e-05	0.000727	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CXCL12—systemic lupus erythematosus	9.51e-05	0.000724	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—C3—systemic lupus erythematosus	9.42e-05	0.000717	CbGpPWpGaD
Methamphetamine—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	9.28e-05	0.000707	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	9.12e-05	0.000695	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—F2—systemic lupus erythematosus	9.1e-05	0.000693	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—JAK1—systemic lupus erythematosus	9.09e-05	0.000693	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—CCL2—systemic lupus erythematosus	9.07e-05	0.000691	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CXCL12—systemic lupus erythematosus	8.88e-05	0.000677	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	8.87e-05	0.000676	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—RXRA—systemic lupus erythematosus	8.85e-05	0.000674	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TLR9—systemic lupus erythematosus	8.62e-05	0.000657	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—IL2RA—systemic lupus erythematosus	8.49e-05	0.000647	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—P2RY12—systemic lupus erythematosus	8.35e-05	0.000636	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	8.35e-05	0.000636	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	8.28e-05	0.000631	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—F2—systemic lupus erythematosus	8.27e-05	0.00063	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	8.26e-05	0.000629	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	8.21e-05	0.000625	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—ALB—systemic lupus erythematosus	8.09e-05	0.000616	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IL2—systemic lupus erythematosus	8.08e-05	0.000616	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TLR9—systemic lupus erythematosus	8.05e-05	0.000613	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—IL6—systemic lupus erythematosus	8.04e-05	0.000613	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	7.95e-05	0.000605	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	7.88e-05	0.000601	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—NAT2—systemic lupus erythematosus	7.82e-05	0.000596	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—P2RY12—systemic lupus erythematosus	7.8e-05	0.000594	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—NOS3—systemic lupus erythematosus	7.74e-05	0.00059	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CSK—systemic lupus erythematosus	7.68e-05	0.000585	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—MMP9—systemic lupus erythematosus	7.65e-05	0.000583	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7.62e-05	0.000581	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—JAK1—systemic lupus erythematosus	7.57e-05	0.000577	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—ALB—systemic lupus erythematosus	7.56e-05	0.000576	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	7.53e-05	0.000574	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	7.41e-05	0.000565	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	7.39e-05	0.000563	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—F2—systemic lupus erythematosus	7.39e-05	0.000563	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—CCL2—systemic lupus erythematosus	7.37e-05	0.000561	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	7.36e-05	0.000561	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—EP300—systemic lupus erythematosus	7.25e-05	0.000553	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—NOS3—systemic lupus erythematosus	7.23e-05	0.000551	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CXCL12—systemic lupus erythematosus	7.22e-05	0.00055	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CCR5—systemic lupus erythematosus	7.18e-05	0.000547	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CSK—systemic lupus erythematosus	7.18e-05	0.000547	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—JAK1—systemic lupus erythematosus	7.08e-05	0.000539	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	7.07e-05	0.000539	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NCF2—systemic lupus erythematosus	7.03e-05	0.000535	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—C3—systemic lupus erythematosus	7.01e-05	0.000534	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—LYN—systemic lupus erythematosus	6.98e-05	0.000532	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—JAK1—systemic lupus erythematosus	6.88e-05	0.000524	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.87e-05	0.000523	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SH2B3—systemic lupus erythematosus	6.85e-05	0.000522	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	6.73e-05	0.000513	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CCR5—systemic lupus erythematosus	6.7e-05	0.000511	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	6.61e-05	0.000503	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PPARG—systemic lupus erythematosus	6.6e-05	0.000503	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NCF2—systemic lupus erythematosus	6.56e-05	0.0005	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—RXRA—systemic lupus erythematosus	6.56e-05	0.0005	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—IL2—systemic lupus erythematosus	6.56e-05	0.0005	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—C3—systemic lupus erythematosus	6.55e-05	0.000499	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TLR9—systemic lupus erythematosus	6.54e-05	0.000498	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—LYN—systemic lupus erythematosus	6.52e-05	0.000497	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CCR5—systemic lupus erythematosus	6.52e-05	0.000497	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—JAK1—systemic lupus erythematosus	6.42e-05	0.000489	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL2RA—systemic lupus erythematosus	6.42e-05	0.000489	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SH2B3—systemic lupus erythematosus	6.4e-05	0.000487	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—C3—systemic lupus erythematosus	6.37e-05	0.000485	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—P2RY12—systemic lupus erythematosus	6.33e-05	0.000483	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	6.31e-05	0.00048	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—F2—systemic lupus erythematosus	6.16e-05	0.000469	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—ALB—systemic lupus erythematosus	6.14e-05	0.000468	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—IL2—systemic lupus erythematosus	6.13e-05	0.000467	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CCR5—systemic lupus erythematosus	6.09e-05	0.000464	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL2RA—systemic lupus erythematosus	6e-05	0.000457	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	5.98e-05	0.000456	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—C3—systemic lupus erythematosus	5.95e-05	0.000453	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—ALB—systemic lupus erythematosus	5.94e-05	0.000452	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—EP300—systemic lupus erythematosus	5.89e-05	0.000449	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—NOS3—systemic lupus erythematosus	5.87e-05	0.000447	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CSK—systemic lupus erythematosus	5.83e-05	0.000444	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—F2—systemic lupus erythematosus	5.75e-05	0.000438	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—JAK1—systemic lupus erythematosus	5.75e-05	0.000438	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—NOS3—systemic lupus erythematosus	5.68e-05	0.000433	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CXCL12—systemic lupus erythematosus	5.62e-05	0.000428	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—F2—systemic lupus erythematosus	5.59e-05	0.000426	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PPARG—systemic lupus erythematosus	5.59e-05	0.000426	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—VEGFA—systemic lupus erythematosus	5.58e-05	0.000425	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—JUNB—systemic lupus erythematosus	5.51e-05	0.00042	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—EP300—systemic lupus erythematosus	5.5e-05	0.000419	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	5.45e-05	0.000415	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—RXRA—systemic lupus erythematosus	5.4e-05	0.000411	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	5.37e-05	0.000409	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NCF2—systemic lupus erythematosus	5.33e-05	0.000406	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—C3—systemic lupus erythematosus	5.32e-05	0.000405	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—LYN—systemic lupus erythematosus	5.3e-05	0.000403	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CXCL12—systemic lupus erythematosus	5.25e-05	0.0004	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—RASGRP1—systemic lupus erythematosus	5.24e-05	0.000399	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—F2—systemic lupus erythematosus	5.22e-05	0.000398	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—JAK1—systemic lupus erythematosus	5.22e-05	0.000398	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—VEGFA—systemic lupus erythematosus	5.21e-05	0.000397	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SH2B3—systemic lupus erythematosus	5.2e-05	0.000396	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PTGS2—systemic lupus erythematosus	5.19e-05	0.000396	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—JUNB—systemic lupus erythematosus	5.15e-05	0.000392	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—TGFB1—systemic lupus erythematosus	5.12e-05	0.00039	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	5.1e-05	0.000388	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PRL—systemic lupus erythematosus	5.08e-05	0.000387	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—ALB—systemic lupus erythematosus	5.02e-05	0.000383	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CCL2—systemic lupus erythematosus	4.98e-05	0.00038	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—IL2—systemic lupus erythematosus	4.98e-05	0.000379	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCR5—systemic lupus erythematosus	4.95e-05	0.000377	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—RASGRP1—systemic lupus erythematosus	4.89e-05	0.000373	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	4.87e-05	0.000371	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—C3—systemic lupus erythematosus	4.83e-05	0.000368	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—NOS3—systemic lupus erythematosus	4.81e-05	0.000366	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—TGFB1—systemic lupus erythematosus	4.78e-05	0.000364	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IL6—systemic lupus erythematosus	4.75e-05	0.000362	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PRL—systemic lupus erythematosus	4.75e-05	0.000362	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—F2—systemic lupus erythematosus	4.67e-05	0.000356	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CCL2—systemic lupus erythematosus	4.66e-05	0.000355	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—TYK2—systemic lupus erythematosus	4.53e-05	0.000345	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—EP300—systemic lupus erythematosus	4.47e-05	0.00034	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PTGS2—systemic lupus erythematosus	4.4e-05	0.000335	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—RXRA—systemic lupus erythematosus	4.38e-05	0.000334	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—EP300—systemic lupus erythematosus	4.32e-05	0.000329	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCL12—systemic lupus erythematosus	4.26e-05	0.000325	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—F2—systemic lupus erythematosus	4.24e-05	0.000323	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—VEGFA—systemic lupus erythematosus	4.23e-05	0.000322	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—TYK2—systemic lupus erythematosus	4.23e-05	0.000322	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—JUNB—systemic lupus erythematosus	4.18e-05	0.000319	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—IL2—systemic lupus erythematosus	4.15e-05	0.000316	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PPARG—systemic lupus erythematosus	4.14e-05	0.000316	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—JAK1—systemic lupus erythematosus	4.06e-05	0.00031	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.98e-05	0.000303	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TGFB1—systemic lupus erythematosus	3.88e-05	0.000296	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.87e-05	0.000295	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PRL—systemic lupus erythematosus	3.85e-05	0.000294	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCR5—systemic lupus erythematosus	3.85e-05	0.000293	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—JAK1—systemic lupus erythematosus	3.8e-05	0.000289	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.79e-05	0.000289	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCL2—systemic lupus erythematosus	3.78e-05	0.000288	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL2—systemic lupus erythematosus	3.77e-05	0.000287	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—C3—systemic lupus erythematosus	3.76e-05	0.000287	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ALB—systemic lupus erythematosus	3.73e-05	0.000284	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—EP300—systemic lupus erythematosus	3.66e-05	0.000278	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCR5—systemic lupus erythematosus	3.6e-05	0.000274	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—NOS3—systemic lupus erythematosus	3.56e-05	0.000272	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.54e-05	0.00027	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL2—systemic lupus erythematosus	3.52e-05	0.000268	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—C3—systemic lupus erythematosus	3.51e-05	0.000268	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.43e-05	0.000262	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PPARG—systemic lupus erythematosus	3.41e-05	0.00026	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—F2—systemic lupus erythematosus	3.3e-05	0.000252	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTGS2—systemic lupus erythematosus	3.26e-05	0.000248	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CD80—systemic lupus erythematosus	3.17e-05	0.000241	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.15e-05	0.00024	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—F2—systemic lupus erythematosus	3.09e-05	0.000235	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—JAK1—systemic lupus erythematosus	3.08e-05	0.000235	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ALB—systemic lupus erythematosus	3.06e-05	0.000233	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CD80—systemic lupus erythematosus	2.96e-05	0.000225	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCL2—systemic lupus erythematosus	2.94e-05	0.000224	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—NOS3—systemic lupus erythematosus	2.93e-05	0.000223	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCR5—systemic lupus erythematosus	2.92e-05	0.000223	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.88e-05	0.000219	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL2—systemic lupus erythematosus	2.86e-05	0.000218	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	2.86e-05	0.000218	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—C3—systemic lupus erythematosus	2.85e-05	0.000217	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PPARG—systemic lupus erythematosus	2.77e-05	0.000211	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCL2—systemic lupus erythematosus	2.75e-05	0.00021	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—EP300—systemic lupus erythematosus	2.71e-05	0.000207	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTGS2—systemic lupus erythematosus	2.68e-05	0.000204	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TYK2—systemic lupus erythematosus	2.67e-05	0.000204	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NOS3—systemic lupus erythematosus	2.62e-05	0.0002	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—F2—systemic lupus erythematosus	2.51e-05	0.000191	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TYK2—systemic lupus erythematosus	2.5e-05	0.00019	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ALB—systemic lupus erythematosus	2.49e-05	0.00019	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NOS3—systemic lupus erythematosus	2.45e-05	0.000187	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CD80—systemic lupus erythematosus	2.4e-05	0.000183	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—NOS3—systemic lupus erythematosus	2.38e-05	0.000181	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.27e-05	0.000173	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCL2—systemic lupus erythematosus	2.23e-05	0.00017	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—EP300—systemic lupus erythematosus	2.23e-05	0.00017	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL2—systemic lupus erythematosus	2.22e-05	0.000169	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL6—systemic lupus erythematosus	2.21e-05	0.000169	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTGS2—systemic lupus erythematosus	2.18e-05	0.000166	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.12e-05	0.000162	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MMP9—systemic lupus erythematosus	2.11e-05	0.00016	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.1e-05	0.00016	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL2—systemic lupus erythematosus	2.08e-05	0.000158	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6—systemic lupus erythematosus	2.07e-05	0.000158	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TYK2—systemic lupus erythematosus	2.03e-05	0.000155	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—EP300—systemic lupus erythematosus	2e-05	0.000152	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NOS3—systemic lupus erythematosus	1.99e-05	0.000152	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MMP9—systemic lupus erythematosus	1.97e-05	0.00015	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.96e-05	0.000149	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.89e-05	0.000144	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—EP300—systemic lupus erythematosus	1.86e-05	0.000142	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—EP300—systemic lupus erythematosus	1.81e-05	0.000138	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	1.8e-05	0.000137	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.77e-05	0.000135	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.74e-05	0.000132	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.72e-05	0.000131	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL2—systemic lupus erythematosus	1.69e-05	0.000129	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.68e-05	0.000128	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	1.62e-05	0.000124	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.62e-05	0.000123	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.6e-05	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.59e-05	0.000121	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	1.55e-05	0.000118	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—EP300—systemic lupus erythematosus	1.51e-05	0.000115	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.43e-05	0.000109	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	1.42e-05	0.000108	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.32e-05	0.0001	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6—systemic lupus erythematosus	1.31e-05	9.96e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6—systemic lupus erythematosus	1.22e-05	9.3e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	1.18e-05	8.99e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6—systemic lupus erythematosus	9.92e-06	7.56e-05	CbGpPWpGaD
